Optimising control of diabetes before surgery
- Conditions
- diabetes mellituspreoperativeglucoseglycaemic controlsuikerziektepreoperatief
- Registration Number
- NL-OMON23762
- Lead Sponsor
- Academic Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Diabetes mellitus type 2 (diagnosis at least 3 months prior to pre-operative screening)
- Age 18 - 85 years
Exclusion Criteria
- Bariatric surgery
- Palliative surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint of the study will be the number of days at home up to 30 days after surgery (DAH30), which is a single,<br>pragmatic, patient-centred outcome.
- Secondary Outcome Measures
Name Time Method Secondary outcomes are preoperative and postoperative blood glucose concentrations, incidence of hyperglycaemia and<br>hypoglycaemia (glucose >10 mmol/l or <4 mmol/l, respectively) and change from baseline HbA1c, fructosamine, and 1,5-<br>anhydroglucitol.